These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23954929)

  • 1. Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples.
    Carter MD; Crow BS; Pantazides BG; Watson CM; DeCastro BR; Thomas JD; Blake TA; Johnson RC
    J Biomol Screen; 2014 Feb; 19(2):325-30. PubMed ID: 23954929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.
    Graham LA; Johnson D; Carter MD; Stout EG; Erol HA; Isenberg SL; Mathews TP; Thomas JD; Johnson RC
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27572107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic detection of organophosphorus nerve agent adducts to butyrylcholinesterase in plasma using liquid chromatography-tandem mass spectrometry combined with an improved procainamide-gel separation and pepsin digestion method.
    Liu CC; Liang LH; Yan L; Chen B; Liu XJ; Yang Y; Liu SL; Xi HL
    J Chromatogr A; 2023 May; 1697():463990. PubMed ID: 37075496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.
    Mathews TP; Carter MD; Johnson D; Isenberg SL; Graham LA; Thomas JD; Johnson RC
    Anal Chem; 2017 Feb; 89(3):1955-1964. PubMed ID: 28208252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based proteomic approach for the screening of butyrylcholinesterase adduct formation with organophosphates.
    Dubrovskii Y; Murashko E; Chuprina O; Beltyukov P; Radilov A; Solovyev N; Babakov V
    Talanta; 2019 May; 197():374-382. PubMed ID: 30771950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.
    Pantazides BG; Watson CM; Carter MD; Crow BS; Perez JW; Blake TA; Thomas JD; Johnson RC
    Anal Bioanal Chem; 2014 Aug; 406(21):5187-94. PubMed ID: 24604326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay for detection of organophosphorylated butyrylcholinesterase: a biomarker of exposure to organophosphate agents.
    Wang L; Du D; Lu D; Lin CT; Smith JN; Timchalk C; Liu F; Wang J; Lin Y
    Anal Chim Acta; 2011 May; 693(1-2):1-6. PubMed ID: 21504805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.
    Carter MD; Crow BS; Pantazides BG; Watson CM; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2013 Nov; 85(22):11106-11. PubMed ID: 24205842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detectable organophosphorus pesticide exposure in the blood of Nebraska and Iowa residents measured by mass spectrometry of butyrylcholinesterase adducts.
    Jiang W; Lockridge O
    Chem Biol Interact; 2013 Mar; 203(1):91-5. PubMed ID: 22989774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
    Reiner E; Radić Z; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
    Carletti E; Schopfer LM; Colletier JP; Froment MT; Nachon F; Weik M; Lockridge O; Masson P
    Chem Res Toxicol; 2011 Jun; 24(6):797-808. PubMed ID: 21438623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.
    Jońca J; Żuk M; Wasąg B; Janaszak-Jasiecka A; Lewandowski K; Wielgomas B; Waleron K; Jasiecki J
    PLoS One; 2015; 10(10):e0139480. PubMed ID: 26444431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
    Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
    Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive expansion of albumin adducts for organophosphorus nerve agent traceability based on single and group adduct collection.
    Wang J; Lu X; Gao R; Pei C; Wang H
    Anal Bioanal Chem; 2024 Jun; 416(15):3569-3584. PubMed ID: 38698257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.